“Patients typically develop a high fever, their Interleukin 6 (IL-6) is high. If we can get them to pass the two-week mark, they will survive.”Dr. Masab Moumneh, MD, ICU physician
While we have been battling with sepsis for centuries, now COVID19 added new challenges to this battle. Can Aquaporin-based therapy be our newest weapon against this malicious viral sepsis?
Sepsis – an elusive syndrome